James Matcham
Impact in
- Hematology top 1%
- Erythropoietin and Anemia Treatment
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Platelet Disorders and Treatments
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
Papers in
- Hematology 11
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 6
-
- Statistical Methods in Clinical Trials 10
- Co-authors
- Klaus Lechner (6 shared papers)Gerhard Heil (6 shared papers)Miguel Á. Sanz (6 shared papers)Alan Barge (5 shared papers)Dieter Hoelzer (4 shared papers)John A. Liu Yin (4 shared papers)Jeff Szer (4 shared papers)L. Noens (4 shared papers)
- Journals
- Pharmaceutical Statistics (7 papers)Blood (4 papers)Bone Marrow Transplantation (2 papers)Statistics in Biopharmaceutical Research (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United KingdomGermanyFrance
In The Last Decade
James Matcham
25 papers receiving 1.3k citations
James Matcham's Hit Papers
Peers
Comparison fields: 5 of 121
- Hematology 642
- Statistics and Probability 119
- Oncology 293
- Genetics 113
- Biochemistry 58
Countries citing papers authored by James Matcham
This map shows the geographic impact of James Matcham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Matcham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Matcham more than expected).
Fields of papers citing papers by James Matcham
This network shows the impact of papers produced by James Matcham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Matcham. The network helps show where James Matcham may publish in the future.
Co-authors
The 25 scholars most cited alongside James Matcham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of a five-dimensional framework on R&D productivity at AstraZeneca Hit paper breakdown → | 2018 | 302 |
| 2 | 2003 | 275 | |
| 3 | 1997 | 253 | |
| 4 | 1999 | 87 | |
| 5 | 1991 | 84 | |
| 6 | 2003 | 69 | |
| 7 | Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. | 2005 | 48 |
| 8 | 2017 | 45 | |
| 9 | 2011 | 36 | |
| 10 | 2016 | 34 | |
| 11 | 1997 | 34 | |
| 12 | 2009 | 22 | |
| 13 | 2013 | 18 | |
| 14 | 2006 | 17 | |
| 15 | 2010 | 13 | |
| 16 | 2010 | 13 | |
| 17 | 2007 | 13 | |
| 18 | Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia | 1995 | 12 |
| 19 | 1997 | 11 | |
| 20 | 1991 | 6 |
About James Matcham
James Matcham is a scholar working on Hematology, Statistics and Probability, Economics and Econometrics, Oncology and Molecular Biology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (10 papers), Hematopoietic Stem Cell Transplantation (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Acute Myeloid Leukemia Research (6 papers), Neutropenia and Cancer Infections (5 papers), Pharmaceutical industry and healthcare (3 papers), Computational Drug Discovery Methods (3 papers) and Optimal Experimental Design Methods (2 papers). The work is most often cited by research in Hematology (642 citations), Statistics and Probability (119 citations), Oncology (293 citations), Genetics (113 citations) and Biochemistry (58 citations). James Matcham has collaborated with scholars based in United Kingdom, Germany and France. Frequent co-authors include Klaus Lechner, Gerhard Heil, Miguel Á. Sanz, Alan Barge, Dieter Hoelzer, John A. Liu Yin, Jeff Szer, L. Noens, Arnold Ganser and Giuseppe Francesco Sferrazza Papa. Their work appears in journals such as Pharmaceutical Statistics, Blood, Bone Marrow Transplantation, Statistics in Biopharmaceutical Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.